top of page

Using Biosimulation to Develop Pediatric Therapeutics

An Empowered Patient Podcast

Using Biosimulation to Develop Pediatric Therapeutics with Lynne Georgopoulos of Certara

An Empowered Patient Podcast, hosted by Karen Jagoda

Lynne Georgopoulos, VP Regulatory Strategy, Certara describes the company's platform to optimize pediatric drug development using biosimulation. With an eye on pediatric diseases, Certara is employing modeling and simulation to determine how a drug developed for adults may be metabolized in children, including neonates. They are also operationalizing clinical trials to be more efficient and potentially less invasive which is important when working with young children.

To listen to the podcast:

Transcript of the podcast:

Certara website:

Empowered Patient website:

Medical and Pharma Insider website:

bottom of page